/ News

Campaign gathers health professionals for fundraising to finance clinical researches

An ongoing campaign in the social media, developed by the Cure Project, is gathering oncologists and additional health professionals, to raise funds to finance the Phase III of the clinical research Neosamba, which scope is to study a way to prevent the relapse of HER2-negative breast cancer in patients.

The objective of such campaign is that the participants – godfathers and godmothers – share in their social media a customized link for online fundraising and encourage their followers to donate funds for the research. Every participant sets his/her fundraising target, while a ranking shows the results of his/her fundraising performance.

According to Fernanda Schwyter, president of the Cure Project, this campaign is a healthy competition to support a great cause. “That was the way we found to engage physicians and additional health professionals in the search for private funds to support the clinical researches to fight cancer, just a great initiative”, she explains.

So far the physicians joining the “contest” are as follows: Heloisa Resende (RJ), Susana Ramalho (RJ ) Monique Binotto (RS), Alessandra Morelle (RS),  José Bines (RJ), Tomas Reinert (RS), Gilberto Amorim (RJ), Gustavo Werutsky (RS), Eduardo Romero( (SP), in addition to Flávia dos Santos (Bogota – Colombia ), phycologist and sexologist.  The webpage of the Cure Project is also participating in such contest.

With the slogan “The cure of cancer is in our hands”, the Cure Project has been carrying out several activities directed towards arts, music, fashion and entertainment, aiming at developing a philanthropy culture to finance clinical researches in Brazil.

The Neosamba  research, coordinated and managed by LACOG – Latin American Cooperative Oncology Group, is 100% Brazilian and will be conducted with SUS patients at 12 oncological centers installed in eight Brazilian states.

For further information and participation: https://linktr.ee/projetocura

/ SHARE
Tweet about this on TwitterShare on FacebookGoogle+